Clinical Trials Browser

Withdrawn × pazopanib × Breast × Clear all

NCT00615524 2018-01-12

Phase II Study Evaluating Exemestane Alone Or In Combination With Pazopanib In Postmenopausal Women With Hormone Receptor Positive Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms, Neoplasm Metastasis